Clusterin levels in plasma predict cognitive decline and progression to Alzheimer's disease

Manuscript Number: 

15-0036R1

Author(s): 
Marinus A. Blankenstein, Wesley Jongbloed, Sandra D. Mulder, Robert Veerhuis, Karin D. van Dijk, Wilma D.J. van de Berg, Wiesje M. van der Flier

Disclosures

Marinus A. Blankenstein

  • Nothing to Disclose

Wesley Jongbloed

  • Nothing to Disclose

Sandra D. Mulder

  • Nothing to Disclose

Wilma D.J. van de Berg

  • Lecture Fees:
    Flight and accomodation for AD/PD conference, Nice 2015, was paid by Prothena
    Grants
    • Agency: 
      Roche Pharma Research
      Dates: 
      Sept 2014 and Jan 2015

Wiesje M. van der Flier

  • Nothing to Disclose

Karin D. van Dijk

  • Nothing to Disclose

Robert Veerhuis

  • Nothing to Disclose